5 Key Takeaways

• 1

  The EU's Medical Device Regulation (MDR) significantly reshaped medical device assessment and approval processes to enhance patient safety.

• 2

  MDR introduced stricter clinical evidence requirements, mandatory post-market surveillance, and improved traceability through Unique Device Identification.

• 3

  Manufacturers face extended review timelines and increased compliance costs, leading some to withdraw products from the European market.

• 4

  MDR certification has become a benchmark for operational preparedness and a key differentiator in the competitive medtech landscape.

• 5

  Regulatory readiness is now central to maintaining market access in Europe, as compliance challenges continue to impact innovation and supply chains.